Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non-cash Items (2016 - 2018)

Lifecore Biomedical, Inc. \De\ has reported Non-cash Items over the past 4 years, most recently at $1.4 million for Q2 2018.

  • Quarterly results put Non-cash Items at $1.4 million for Q2 2018, up 1.56% from a year ago — trailing twelve months through May 2018 was $1.4 million (up 1.56% YoY), and the annual figure for FY2018 was $1.4 million, up 1.56%.
  • Non-cash Items for Q2 2018 was $1.4 million at Lifecore Biomedical, Inc. \De\, up from $1.4 million in the prior quarter.
  • Over the last five years, Non-cash Items for LFCR hit a ceiling of $2.7 million in Q2 2015 and a floor of $216687.0 in Q2 2016.
  • Median Non-cash Items over the past 4 years was $1.4 million (2017), compared with a mean of $1.4 million.
  • Biggest five-year swings in Non-cash Items: tumbled 92.11% in 2016 and later soared 528.79% in 2017.
  • Lifecore Biomedical, Inc. \De\'s Non-cash Items stood at $2.7 million in 2015, then tumbled by 92.11% to $216687.0 in 2016, then soared by 528.79% to $1.4 million in 2017, then grew by 1.56% to $1.4 million in 2018.
  • The last three reported values for Non-cash Items were $1.4 million (Q2 2018), $1.4 million (Q2 2017), and $216687.0 (Q2 2016) per Business Quant data.